Fevertree Drinks Share Discussion Threads

[bulltradept] 12/9/2023 07:36

Should be market down, I concur.

[agnes] 12/9/2023 07:32

Would be surprised if this isn't marked down at the off. A great brand but there's always something- bad weather, production issue or de-stocking that delays cash flow generation. Strategically valuable but stand alone looks expensive imo

[johndoe23] 12/9/2023 07:25

Don't look very good to me. Cash down, margins have shrunk, earnings miniscule, sky high historic PE. US doing well but everywhere else not so.

[terminator101] 12/9/2023 07:13

Operating profit just £0.6 million. Down 96% All the rest is just waffle#overvalued.

[panamapapers] 24/8/2023 19:49

12th of September.

[gswredland] 15/8/2023 16:15

When is the trading update guys please?

[castleford tiger] 01/8/2023 08:49

All this talk of doing well and we forecast 36/42 ebitda

Flat profits from last year.

We have just had an awful July weather wise and August has started as bad.

I think they will miss targets.

Shares are too high in my opinion

tiger

[edwardt] 19/7/2023 08:14

Boom - double upgrade by exane

[trident5] 17/7/2023 11:36

At Fevertree?

[edwardt] 17/7/2023 10:36

Sales / volumes

[trident5] 17/7/2023 10:05

Growth of what?

[edwardt] 17/7/2023 08:58

Nielsen June data shows strong growth on continent and US . Even U.K. doing well

[emeraldzebra] 30/6/2023 14:16

Am I the only one that things this one is behaving weirdly.? It’s all over the place with no news. And v little reaction here too. I suppose it’s just one to tuck away sand forget, if not needing the cash.

[gswredland] 30/6/2023 10:11

Ah yes see that now buoy. Sorry
Thanks
Market weakness currently responsible but I am still wary of the high PE here

[buoycat] 30/6/2023 09:27

They made a trading statement only a month ago saying everything was in line.

[gswredland] 30/6/2023 09:17

Profit warning coming?

[disc0dave45] 08/6/2023 17:38

FEVR - better to under promise than over promise. Doubt it's lost on them that their forecasts contradict their "margin improvements" for FY23.DOCS - Wasn't brilliant, fairly flat earnings now unless the BB is their ace up the sleeve to deliver a beat. Did post up.

[apad] 08/6/2023 12:09

Good interchange.
Appreciated.
apad

[disc0dave45] 08/6/2023 12:04

AndyThanks for posting, tend to agree as even best case their EBITDA margin will be lower than last year at 10.8%.They have mentioned previously that due to energy costs for glass production that this alone is likely to incur £20m in additional input costs for FY23. So perhaps any decent reduction here (+20%) could push margins above last year and a beat rather than a profit warn could be on the cards. Who knows but for me their freight and glass costs will at some point normalise to return to bottom line growth - can't see them changing product pricing anytime soon.

[castleford tiger] 07/6/2023 12:55

evenue
UK 116.2 118.3 (2)%
US 95.6 77.9 23%
Europe (Fever-Tree brand
revenue) 89.2 78.6 13%
Europe total revenue* 101.0 88.2 14%
ROW 31.5 26.7 18%
Total 344.3 311.1 11%

Gross profit 118.8 130.9 (9)%
Gross margin 34.5% 42.1% (760)bps

Adjusted EBITDA[1] 39.7 63.0 (37)%
Adjusted EBITDA margin 11.6% 20.2% (870)bps

Diluted EPS (pence per share) 21.32 38.19 (44)%

Ordinary Dividend (pence
per share) 16.31 15.99 2%

Net cash 95.3 166.2 (43)%
------------------------------- ------ ------ ----

The above is from the last results.

What i dont get is that 390/405m is guidance for the current year.

However EBITDA is only 36/42 million.

So £50m plus growth but nothing falling to the bottom line.

So either pricing is wrong or they are giving margin away for growth ?

I think the period has been behind forecasts and a profit warning might be coming.

As a distributor there is a slow down in gin sales etc.

Diluted eps in the low 20`s means this is on a p/e of 65 times.

DYOR

Tiger

[1224saj] 05/5/2023 20:53

So you bought at 850, surprised you didn't sell at 1750

[disc0dave45] 05/5/2023 16:35

Https://seekingalpha.com/news/3966479-fevertree-drinks-denies-retained-morgan-stanley-strategic-review